Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.
Plaintiffs and defendants have each been directed to select 10 Uber driver sexual assault lawsuits to serve as potential bellwether trials by February 14, 2025, which will then go through case-specific discovery to prepare for early test trials.
Birth control shot manufacturer supports the consolidation of Depo-Provera brain tumor lawsuits, but argues that the claims should be centralized in the Southern District of New York, where the company is headquartered.
